Stryker Corp
NYSE:SYK
Stryker Corp
NYSE:SYK
Price:
340.735
USD
-1.46%
Market Cap:
$130.3B
Relative Value
The Relative Value of one
SYK
stock under the Base Case scenario is
327.515
USD.
Compared to the current market price of 340.735 USD,
Stryker Corp
is
Overvalued by 4%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
SYK
Relative Value
Base Case
327.515
USD
Overvaluation 4%
Multiples Across Competitors
SYK Competitors Multiples
Stryker Corp Competitors
Stryker Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Stryker Corp
NYSE:SYK
|
132.3B USD | 5.2 | 40.2 | 20.5 | 24.8 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
191.5B USD | 4.3 | 29.3 | 16.8 | 23 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175B USD | 17 | 60.1 | 45.6 | 56 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
114.2B USD | 3.2 | 24.8 | 13.6 | 19.9 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.3B USD | 5.1 | 35.4 | 20.8 | 27.9 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
44.6B EUR | 1.9 | 21.1 | 11.7 | 16.5 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
49.4B USD | 8.1 | 45.8 | 25.3 | 27.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
47.9B USD | 10.9 | 44.3 | 31.5 | 34.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46.5B USD | 2.1 | 26.4 | 10.3 | 17.5 | |
| US |
|
Resmed Inc
NYSE:RMD
|
35B USD | 6.4 | 23.2 | 16.3 | 18.2 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.1B USD | 1.6 | 15.4 | 11.1 | 13.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
